# Justin R. McDonie

> Justin R. McDonie is a post-ipo debt investor at Bridge Bank backing Therapeutics. See 1 investment, round sizes, portfolio and contact details. Updated Oct…

- Type: Angel Investor
- Fund: [Bridge Bank](https://shizune.co/investors/profile/bridge-bank)
- Total investments: 1
- Last investment: Jul 2016
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/justin-mcdonie-52a20a6

Justin R. McDonie is a post-ipo debt investor at Bridge Bank focused on Therapeutics and Biotechnology. Justin R. McDonie is the Managing Director of Life Sciences at Signature Bank. He was a former Director at Oxford Finance LLC.Mr. McDonie joined Oxford in 2007 and has underwritten over $250 million of credit to biotechnology and medical device companies. He is currently responsible for originating financings for United States life sciencescompanies in the Mid-Atlantic, Midwest, and Southeast. In addition, he manages relationships with premier venture capital firms and is a liaison to several of Oxford’s portfolio companies. Prior to joining Oxford, he was an analyst at Capital Automotive where he underwrote over $500 million in acquisitions and managed a portion of a $3.7 billion portfolio. Mr. McDonie holds a B.A. in Economics and Commerce from Hampden-Sydney College.

## Contacts

5 contacts available for Justin R. McDonie: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/justin-r-mcdonie?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cytosorbents | CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surfaceadsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies. | $10M | Post-IPO Debt | Jul 01, 2016 | http://cytosorbents.com |

1 of 1 investments shown.

## About Bridge Bank

VC Fund · San Jose, United States

Founded in May 2001, Bridge Bank is the brainchild of some of the most experienced and creative bankers and business people in our community. Our vision was to create a bank that reflects the unique needs of our business community. By combining the resources and services typically associated with larger banks with an unparalleled commitment topersonal service. Bridge Bank offers banking solutions created specifically to help your business grow and prosper.We understand that successful businesses - and the people who run them - have distinctive needs and attributes and our philosophy reflects this understanding. Like our clients, we are committed to being relationship-driven, fast paced and flexible, globally savvy, and technologically advanced.

5 contacts available at Bridge Bank.

| Name | Title | Profile |
| --- | --- | --- |
| Al Williams | EVP & CCO | https://shizune.co/investors/profile/al-williams |
| Bill Wickline | Managing Director Life Sciences Group | https://shizune.co/investors/profile/bill-wickline |
| Blake Reid | Senior Director of Tech and Innovation Banking | https://shizune.co/investors/profile/blake-reid |
| Brian Kirkpatrick | VP | https://shizune.co/investors/profile/brian-kirkpatrick-0adb |
| Daniel P. Myers | President & CEO | https://shizune.co/investors/profile/daniel-p-myers |

## Similar investors

### Similar stage
- [Export Development Canada](https://shizune.co/investors/profile/export-development-canada) — VC Fund
- [BNP Paribas](https://shizune.co/investors/profile/bnp-paribas) — VC Fund
- [Canada Economic Development for Quebec Regions](https://shizune.co/investors/profile/canada-economic-development-for-quebec-regions) — VC Fund

## FAQ

### What does Justin R. McDonie invest in?

Justin R. McDonie invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Post-IPO Debt stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Justin R. McDonie?

Public channels for Justin R. McDonie include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Justin R. McDonie last invest?

The most recent investment recorded for Justin R. McDonie closed in Jul 2016. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co